Page last updated: 2024-11-05

lead sulfate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

lead sulfate: RN given refers to cpd with MF of Pb-SO4 [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID24008
MeSH IDM0101907

Synonyms (66)

Synonym
lead(ii) sulfate
hb 2000
einecs 231-198-9
natural anglesite
lead sulphate
mulhouse white
sulfuric acid, lead(2+) salt (1:1)
sulfuric acid, lead(2+) salt
ccris 8930
hsdb 6308
un1794
anglislite
fast white
lead(ii) sulfate (1:1)
c.i. 77630
milk white
freemans white lead
ts 100 (sulfate)
lead(+2) sulfate
lead monosulfate
ci 77630
sulfate de plomb [french]
bleisulfat [german]
lead bottoms
lead sulfate
7446-14-2
tetrabasic lead sulfate
anglesite
pbso4
lead(2+) sulfate
einecs 258-142-6
sulfuric acid, lead salt, tetrabasic
52732-72-6
90583-07-6
einecs 292-204-3
sulfuric acid, lead(2+) salt, basic
unii-c516h654o8
lead sulfate with >3% free acid
c516h654o8 ,
bleisulfat
ec 231-198-9
lead sulfate with >3% free acid [un1794] [corrosive]
sulfate de plomb
sulphuric acid, lead salt
sulfuric acid, lead salt
sulfuric acid, lead salt (1:?)
15739-80-7
einecs 239-831-0
AKOS015902775
lead sulfate [mi]
sulfuric acid lead(2+) salt (1:1)
lead sulfate [who-dd]
lead(+2) sulfate [hsdb]
KEQXNNJHMWSZHK-UHFFFAOYSA-L
lead(ii) sulfate, puratronic
mfcd00011166
DTXSID50883502
pb (s o4)
lead(2+);sulfate
white lead ci pigment white
lead(2+) sulfate(1:1)
sulfato de plomo
lead(2+) sulphate(1:1)
ts-e
ts 100; ts 100 (sulfate)
sublimed white lead

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"The potential hazards of nanoparticles (NPs) to the environment and to living organisms need to be considered for a safe development of nanotechnology."( Influence of PbS nanoparticle polymer coating on their aggregation behavior and toxicity to the green algae Dunaliella salina.
Jahromi, HD; Moradshahi, A; Sheikhi, MH; Zamani, H, 2014
)
0.4
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (1)

PathwayProteinsCompounds
galena oxidation05

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (12.90)18.7374
1990's3 (9.68)18.2507
2000's12 (38.71)29.6817
2010's11 (35.48)24.3611
2020's1 (3.23)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 76.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index76.36 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index4.74 (4.65)
Search Engine Demand Index128.66 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (76.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies3 (8.33%)4.05%
Observational0 (0.00%)0.25%
Other33 (91.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]